Early inhaled glucocorticoid therapy to prevent bronchopulmonary dysplasia

New England Journal of Medicine

Volumn 340, Issue 13, 1999, Pages 1005-1010

  Cole, Cynthia H ^a,d   Colton, Theodore ^b   Shah, Bhavesh L ^a   Abbasi, Soraya ^c   Mackinnon, Brenda L ^a   Demissie, Serkalem ^b   Frantz III, Ivan D ^a  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c PENNSYLVANIA HOSPITAL   (United States)

^d TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE DIPROPIONATE; GLUCOCORTICOID; PLACEBO;

ARTICLE; ARTIFICIAL VENTILATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; INFANT; INHALATIONAL DRUG ADMINISTRATION; LUNG DYSPLASIA; LUNG INJURY; LUNG VENTILATION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEWBORN; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADMINISTRATION, INHALATION; BECLOMETHASONE; BRONCHODILATOR AGENTS; BRONCHOPULMONARY DYSPLASIA; DOUBLE-BLIND METHOD; DRUG ADMINISTRATION SCHEDULE; FEMALE; GLUCOCORTICOIDS; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; MALE; OXYGEN INHALATION THERAPY; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, NEWBORN;

EID: 0033118991     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJM199904013401304     Document Type: Article

References (33)

1. Pierce MR, Bancalari E. The role of inflammation in the pathogenesis of bronchopulmonary dysplasia. Pediatr Pulmonol 1995;19:371-8.
2. Bhuta T, Ohlsson A. Systematic review and meta-analysis of early postnatal dexamethasone for prevention of chronic lung disease. Arch Dis Child Fetal Neonatal Ed 1998;79:F26-F33.
3. Yeh TF, Torre JA, Rastogi A, Anyebuno MA, Pildes RS. Early postnatal dexamethasone therapy in premature infants with severe respiratory distress syndrome: a double-blind, controlled study. J Pediatr 1990;117:273-82.
4. Sanders RJ, Cox C, Phelps DL, Sinkin RA. Two doses of early intravenous dexamethasone for the prevention of bronchopulmonary dysplasia in babies with respiratory distress syndrome. Pediatr Res 1994;36:122-8.
5. Durand M, Sardesai S, McEvoy C. Effects of early dexamethasone therapy on pulmonary mechanics and chronic lung disease in very low birth weight infants: a randomized, controlled trial. Pediatrics 1995;95:584-90.
6. Rastogi A, Akintorin SM, Bez ML, Morales P, Pildes RS. A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 1996;98:204-10.
7. Yeh TF, Lin YJ, Hsieh WS, et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics 1997;100: 715-6. abstract.
8. Tapia JL, Ramirez R, Cifuentes J, et al. The effect of early dexamethasone administration on bronchopulmonary dysplasia in preterm infants with respiratory distress syndrome. J Pediatr 1998;132:48-52.
9. Cole CH, Frantz ID III. Role of postnatal steroids for neonatal chronic lung disease. In: Hansen TN, McIntosh N, eds. Current topics in neonatology number 2. London: W.B. Saunders, 1997:256-80.
10. Beclovent (beclomethasone dipropionate, USP) inhalation aerosol for oral inhalation only. In: Physicians' desk reference. 51st ed. Montvale, N.J.: Medical Economics, 1997:1063-5.
11. Barnes PJ, Pedersen S. Efficacy and safety of inhaled corticosteroids in asthma: report of a workshop held in Eze, France, October 1992. Am Rev Respir Dis 1993;148:S1-S26.
12. Beclomethasone dipropionate 240 mcg/actuation inhalation aerosol (Becloforte). Clinical investigator brochure. Research Triangle Park, N.C.: Glaxo, February 1990.
13. Tan KL. Blood pressure in very low birth weight infants in the first 70 days of life. J Pediatr 1988;112:266-70.
14. Bell MJ, Ternberg JL, Feigin RD, et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978; 187:1-7
15. Greene MG, ed. The Harriet Lane handbook: a manual for pediatric house officers. 12th ed. St. Louis: Mosby-Year Book, 1991:378-9.
16. Edwards DK. Radiology of hyaline membrane disease, transient tachypnea of the newborn, and bronchopulmonary dysplasia. In: Farrell PM, ed. Lung development: biological and clinical perspectives. Vol. 2. Neonatal respiratory distress. New York: Academic Press, 1982:47-89.
17. Lan KKG, DeMets DL. Discrete sequential boundaries for clinical trials. Biometrika 1983;70:659-63.
18. Yuksel B, Greenough A. Randomised trial of inhaled steroids in preterm infants with respiratory symptoms at follow up. Thorax 1992;47:910-3.
19. Cloutier MM. Nebulized steroid therapy in bronchopulmonary dysplasia. Pediatr Pulmonol 1993;15:111-6.
20. LaForce WR, Brudno DS. Controlled trial of beclomethasone dipropionate by nebulization in oxygen-and ventilator-dependent infants. J Pediatr 1993;122:285-8.
21. Arnon S, Grigg J, Silverman M. Effectiveness of budesonide aerosol in ventilator-dependent preterm babies: a preliminary report. Pediatr Pulmonol 1996;21:231-5.
22. Linder N, Kuint J, German B, Lubin D, Loewenthal R. Hypertrophy of the tongue associated with inhaled corticosteroid therapy in premature infants. J Pediatr 1995;127:651-3.
23. Kovacs L, Davis GM, Faucher D, Papageorgiou A. Efficacy of sequential early systemic and inhaled corticosteroid therapy in the prevention of chronic lung disease of prematurity. Acta Paediatr 1998;87:792-8.
24. Fok TF, Monkman S, Dolovich M, et al. Efficiency of aerosol medication delivery from a metered dose inhaler versus jet nebulizer in infants with bronchopulmonary dysplasia. Pediatr Pulmonol 1996;21:301-9.
25. Grigg J, Arnon S, Jones T, Clarke A, Silverman M. Delivery of therapeutic aerosols to intubated babies. Arch Dis Child 1992;67:25-30.
26. Everard ML. Aerosol delivery in infants and young children. J Aerosol Med 1996;9:71-7.
27. O'Callaghan C. Delivery systems: the science. Pediatr Pulmonol Suppl 1997;15:51-4.
28. O'Callaghan C, Lynch J, Cant M, Robertson C. Improvement in sodium cromoglycate delivery from a spacer device by use of an antistatic lining, immediate inhalation, and avoiding multiple actuations of drug. Thorax 1993;48:603-6.
29. O'Callaghan C. Particle size of beclomethasone dipropionate produced by two nebulisers and two spacing devices. Thorax 1990;45:109-11.
30. Fardy CH, Silverman M. Aerosol therapy in the newborn. In: Neonatal respiratory diseases. Vol. 6. No. 2. 1996. (Newton, Pa.: Associates in Medical Marketing.)
31. Salmon B, Wilson NM, Silverman M. How much aerosol reaches the lungs of wheezy infants and toddlers? Arch Dis Child 1990;65:401-3.
32. Arnon S, Grigg J, Nikander K, Silverman M. Delivery of micronized budesonide suspension by metered dose inhaler and jet nebulizer into a neonatal ventilator circuit. Pediatr Pulmonol 1992;13:172-5.
33. O'Callaghan C, Hardy J, Stammers J, Stephenson TJ, Hull D. Evaluation of techniques for delivery of steroids to lungs of neonates using a rabbit model. Arch Dis Child 1992;67:20-4.